GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Piotroski F-Score

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Piotroski F-Score : 1 (As of May. 25, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 1 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Malaysian Genomics Resource Centre Bhd has an F-score of 1. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Malaysian Genomics Resource Centre Bhd's Piotroski F-Score or its related term are showing as below:

XKLS:0155' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 8
Current: 1

During the past 13 years, the highest Piotroski F-Score of Malaysian Genomics Resource Centre Bhd was 8. The lowest was 1. And the median was 4.


Malaysian Genomics Resource Centre Bhd Piotroski F-Score Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Piotroski F-Score Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 2.00 3.00 7.00 N/A

Malaysian Genomics Resource Centre Bhd Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 5.00 4.00 3.00 1.00

Competitive Comparison of Malaysian Genomics Resource Centre Bhd's Piotroski F-Score

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd's Piotroski F-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Jun22) TTM:
Net Income was 0.847 + -1.233 + -2.862 + -1.448 = RM-4.70 Mil.
Cash Flow from Operations was -10.92 + -8.809 + -0.592 + 0 = RM-20.32 Mil.
Revenue was 3.812 + 1.643 + 0.68 + 2.265 = RM8.40 Mil.
Gross Profit was 3.078 + 0.987 + 0.027 + 1.144 = RM5.24 Mil.
Average Total Assets from the begining of this year (Jun22)
to the end of this year (Sep23) was
(41.889 + 42.484 + 45.131 + 42.11 + 33.716) / 5 = RM41.066 Mil.
Total Assets at the begining of this year (Jun22) was RM41.89 Mil.
Long-Term Debt & Capital Lease Obligation was RM1.70 Mil.
Total Current Assets was RM23.79 Mil.
Total Current Liabilities was RM2.46 Mil.
Net Income was 0.239 + 1.011 + 1.964 + 3.996 = RM7.21 Mil.

Revenue was 9.316 + 7.628 + 5.083 + 6.332 = RM28.36 Mil.
Gross Profit was 1.938 + 2.616 + 3.78 + 5.516 = RM13.85 Mil.
Average Total Assets from the begining of last year (Jun21)
to the end of last year (Jun22) was
(22.783 + 36.028 + 33.068 + 35.105 + 41.889) / 5 = RM33.7746 Mil.
Total Assets at the begining of last year (Jun21) was RM22.78 Mil.
Long-Term Debt & Capital Lease Obligation was RM1.26 Mil.
Total Current Assets was RM30.06 Mil.
Total Current Liabilities was RM1.66 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Malaysian Genomics Resource Centre Bhd's current Net Income (TTM) was -4.70. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Malaysian Genomics Resource Centre Bhd's current Cash Flow from Operations (TTM) was -20.32. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun22)
=-4.696/41.889
=-0.1121058

ROA (Last Year)=Net Income/Total Assets (Jun21)
=7.21/22.783
=0.31646403

Malaysian Genomics Resource Centre Bhd's return on assets of this year was -0.1121058. Malaysian Genomics Resource Centre Bhd's return on assets of last year was 0.31646403. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Malaysian Genomics Resource Centre Bhd's current Net Income (TTM) was -4.70. Malaysian Genomics Resource Centre Bhd's current Cash Flow from Operations (TTM) was -20.32. ==> -20.32 <= -4.70 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun22 to Sep23
=1.702/41.066
=0.04144548

Gearing (Last Year: Jun22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun21 to Jun22
=1.259/33.7746
=0.03727653

Malaysian Genomics Resource Centre Bhd's gearing of this year was 0.04144548. Malaysian Genomics Resource Centre Bhd's gearing of last year was 0.03727653. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep23)=Total Current Assets/Total Current Liabilities
=23.792/2.461
=9.66761479

Current Ratio (Last Year: Jun22)=Total Current Assets/Total Current Liabilities
=30.062/1.663
=18.07696933

Malaysian Genomics Resource Centre Bhd's current ratio of this year was 9.66761479. Malaysian Genomics Resource Centre Bhd's current ratio of last year was 18.07696933. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Malaysian Genomics Resource Centre Bhd's number of shares in issue this year was 135.384. Malaysian Genomics Resource Centre Bhd's number of shares in issue last year was 124.21. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=5.236/8.4
=0.62333333

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=13.85/28.359
=0.48838111

Malaysian Genomics Resource Centre Bhd's gross margin of this year was 0.62333333. Malaysian Genomics Resource Centre Bhd's gross margin of last year was 0.48838111. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun22)
=8.4/41.889
=0.20052997

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun21)
=28.359/22.783
=1.24474389

Malaysian Genomics Resource Centre Bhd's asset turnover of this year was 0.20052997. Malaysian Genomics Resource Centre Bhd's asset turnover of last year was 1.24474389. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+0+0+0+0+1+0
=1

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Malaysian Genomics Resource Centre Bhd has an F-score of 1. It is a bad or low score, which usually implies poor business operation.

Malaysian Genomics Resource Centre Bhd  (XKLS:0155) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Malaysian Genomics Resource Centre Bhd Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines